Sequent Scientific Stock Screener | Share Price & Fundamental Analysis
SEQUENT
Pharmaceuticals
Share Price NSE
₹193.98
▼
-5.45 (-2.73%)
Share Price BSE
₹194.10
▼
-5.30 (-2.66%)
Track Sequent Scientific share price live with TickJournal's free stock screener.
Analyze Sequent Scientific share price history trends and compare 52-week high low
levels.
Calculate SEQUENT stock fair value using fundamental analysis and view live share price charts.
Determine Sequent Scientific share intrinsic value and compare it with current SEQUENT share price.
Record your Sequent Scientific trades in TickJournal's free trading journal and track your portfolio performance.
Sequent Scientific Market Cap
₹5,067.77 Cr.
SEQUENT P/E Ratio (TTM)
165.81
EPS (TTM)
₹0.88
Dividend Yield
-
Debt to Equity
0.71
SEQUENT 52 Week High
₹252.00
Sequent Scientific 52 Week Low
₹126.68
Operating Margin
11.00%
Profit Margin
2.48%
SEQUENT Revenue (TTM)
₹403.00
EBITDA
₹48.00
Net Income
₹10.00
Total Assets
₹1,602.00
Total Equity
₹770.00
Sequent Scientific Share Price History - Stock Screener Chart
Screen SEQUENT historical share price movements with interactive charts. Analyze price trends and patterns.
Sequent Scientific Company Profile - Fundamental Screener
Screen Sequent Scientific company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SEQUENT shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE807F01027
Sequent Scientific Balance Sheet Screener
Screen SEQUENT balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,602 | 1,540 | 1,529 | 1,451 | 1,393 | 1,463 | 1,388 | 1,343 | 1,905 | 1,528 |
| Current Assets | 873 | 811 | 780 | 783 | 714 | 704 | 600 | 538 | 728 | 491 |
| Fixed Assets | 586 | 592 | 605 | 564 | 536 | 577 | 498 | 476 | 684 | 587 |
| Liabilities | ||||||||||
| Total Liabilities | 1,602 | 1,540 | 1,529 | 1,451 | 1,393 | 1,463 | 1,388 | 1,343 | 1,905 | 1,528 |
| Current Liabilities | 327 | 200 | 221 | 199 | 156 | 236 | 207 | 227 | 247 | 290 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 770 | 713 | 749 | 740 | 776 | 732 | 747 | 685 | 994 | 948 |
| Share Capital | 50 | 50 | 50 | 50 | 50 | 50 | 49 | 49 | 49 | 48 |
| Reserves & Surplus | 654 | 607 | 649 | 633 | 678 | 637 | 657 | 599 | 928 | 885 |
Sequent Scientific Income Statement Screener - Profit & Revenue Analysis
Screen Sequent Scientific income statement and profit fundamentals.
Analyze SEQUENT quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sequent Scientific share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 403 | 445 | 426 | 365 | 393 | 373 | 397 | 368 | 334 | 356 | 337 | 388 | 342 | 339 | 378 |
| Expenses | 356 | 391 | 370 | 334 | 348 | 334 | 357 | 432 | 365 | 331 | 307 | 350 | 342 | 335 | 365 |
| EBITDA | 48 | 55 | 56 | 32 | 45 | 39 | 40 | -63 | -31 | 25 | 30 | 37 | 0 | 4 | 13 |
| Operating Profit % | 11.00% | 12.00% | 13.00% | 8.00% | 11.00% | 9.00% | 9.00% | -18.00% | -10.00% | 4.00% | 7.00% | 9.00% | 0.00% | 1.00% | 3.00% |
| Depreciation | 16 | 15 | 16 | 17 | 16 | 17 | 17 | 15 | 14 | 15 | 16 | 13 | 14 | 13 | 14 |
| Interest | 15 | 14 | 14 | 12 | 16 | 14 | 15 | 11 | 11 | 13 | 13 | 6 | 7 | 8 | 10 |
| Profit Before Tax | 16 | 26 | 27 | 3 | 12 | 8 | 8 | -89 | -56 | -3 | 2 | 18 | -21 | -18 | -10 |
| Tax | 6 | 8 | 8 | 1 | 3 | 2 | 2 | 4 | -21 | 4 | -9 | 8 | -6 | -13 | 0 |
| Net Profit | 10 | 18 | 20 | 1 | 9 | 6 | 7 | -92 | -35 | -7 | 11 | 10 | -15 | -4 | -10 |
| EPS | 0.37 | 0.57 | 0.59 | -0.04 | 0.26 | 0.11 | 0.14 | -3.77 | -1.40 | -0.34 | 0.33 | 0.36 | -0.60 | -0.15 | -0.36 |
Sequent Scientific Cash Flow Screener - Liquidity Fundamentals
Screen SEQUENT cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 83 | 31 | 17 | 31 | 115 | 115 | 116 | 45 | -7 | 0 |
| Investing Activities | -25 | -6 | -65 | -94 | 10 | -72 | -68 | 7 | -116 | -311 |
| Financing Activities | -61 | -1 | 32 | 67 | -139 | -43 | -20 | -57 | 147 | 309 |
| Net Cash Flow | -2 | 23 | -16 | 4 | -14 | 0 | 28 | -5 | 24 | -2 |
Sequent Scientific Shareholding Pattern Screener
See Sequent Scientific shareholding pattern with promoter, FII, and DII holdings.
Check Sequent Scientific promoter holding and ownership changes for SEQUENT on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.61% | 52.61% | 52.33% | 61.43% | 52.79% | 52.78% | 52.76% | 52.61% |
| FII Holding | 6.05% | 6.15% | 5.91% | 3.16% | 6.16% | 5.70% | 6.45% | 6.10% |
| DII Holding | 12.82% | 12.98% | 12.91% | 7.35% | 7.59% | 8.06% | 9.99% | 12.02% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.43% | 22.37% | 22.72% | 19.24% | 24.43% | 25.01% | 24.00% | 23.82% |
| Other Holding | 5.09% | 5.89% | 6.13% | 8.83% | 9.02% | 8.45% | 6.80% | 5.46% |
| Shareholder Count | 158,152 | 147,320 | 144,085 | 135,389 | 166,593 | 163,693 | 154,603 | 162,574 |
Sequent Scientific Share Dividend Screener - Share Yield Analysis
Check Sequent Scientific dividend history with payout and yield data.
View Sequent Scientific dividend details including ex-dates and amounts for SEQUENT stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.50 | 0.37% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.20 | 0.26% |
| 2018-March | ₹0.20 | 0.28% |
| 2017-March | ₹0.00 | 0.00% |
Sequent Scientific Stock Index Membership
See which indices include Sequent Scientific stock.
Check SEQUENT index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sequent Scientific Market Events Screener - Corporate Actions
Get Sequent Scientific corporate actions including splits, bonuses, and buybacks.
Check Sequent Scientific stock events that may affect SEQUENT share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.50 /share | -26.73% | ||
| Annual General Meeting | NA | 7.61% | ||
| 2025-12-08 | 2025-12-08 | Merger - Demerger | 100:56 | 0.00% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 6.35% |
| 2025-08-30 | 2025-08-30 | Extraordinary General Meeting | NA | -2.53% |
| 2025-08-26 | 2025-08-26 | Extraordinary General Meeting | NA | -0.29% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -0.48% |
| 2025-08-08 | 2025-08-08 | Annual General Meeting | NA | -3.66% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 15.69% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -2.09% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -3.87% |
Sequent Scientific Competitors Screener - Peer Comparison
Screen SEQUENT competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 387,205 | 38.30 | 54,729 | 9.71% | 10,980 | 26.52 |
| Divis Laboratories | 159,626 | 65.60 | 9,712 | 18.67% | 2,191 | 29.62 |
| Torrent Pharmaceuticals | 134,593 | 64.70 | 11,539 | 6.99% | 1,911 | 56.71 |
| Cipla | 111,343 | 20.68 | 28,410 | 7.12% | 5,291 | 23.28 |
| Lupin | 99,048 | 22.89 | 22,910 | 13.74% | 3,306 | 57.69 |
| Dr Reddys Laboratories | 97,376 | 16.97 | 33,741 | 16.73% | 5,725 | 23.20 |
| Zydus Life Science | 87,884 | 17.63 | 23,511 | 18.55% | 4,615 | 34.17 |
| Mankind Pharma | 87,692 | 49.29 | 12,744 | 20.90% | 2,007 | 40.97 |
| Alkem Laboratories | 68,397 | 28.48 | 13,458 | 3.70% | 2,216 | 52.47 |
| Aurobindo Pharma | 66,310 | 19.82 | 32,346 | 9.43% | 3,484 | 35.55 |
Sequent Scientific Company Announcements - News Screener
Screen SEQUENT latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-21 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2026-01-09 | Intimation Of Change Of Name Of The Company. | View |
| 2026-01-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-30 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-12-29 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-12-23 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-19 | Closure of Trading Window | View |
| 2025-12-17 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-17 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-16 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | View |
| 2025-12-16 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-16 | Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2025 (SEBI Listing Regulations) And Outcome Of Board Meeting Of The Company | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-11-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-28 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-11-28 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | View |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-11-26 | Intimation Of Record Date Under Regulation 42 Of SEBI | View |
| 2025-11-22 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | View |